Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Experimenting with disembodied human brain might better approximate ground truth but could lack statistical assurance.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Same author

Linking primary cilia defects to the "Big 3" neurodegenerative diseases - causal, consequential, or correlative?

EXCLI journal·2026

Same author

Possible misplaced perception of moral shame in AI-use disclosure.

Accountability in research·2026

Same author

Letter to the Editor: Citations of Retracted Publications Should Be Discounted From One's Bibliometric Indicator.

Journal of Korean medical science·2026

Same author

Primary cilium and TULP3-dependent ciliary targeting of ACE2 in SARS-CoV-2 tropism.

Cell communication and signaling : CCS·2025

Same author

Applying the non-maleficence principle to basic research in Alzheimer's disease.

Indian journal of medical ethics·2025

Search research articles

Related Experiment Video

Updated: Dec 30, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

Maturing iPSC-Derived Cardiomyocytes.

Bor Luen Tang^1,2

¹Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 117596 Singapore, Singapore.

|January 19, 2020

Summary

Human-induced pluripotent stem cells (hiPSCs) offer a new way to generate patient-specific cardiomyocytes for studying cardiovascular disease. This technology enables personalized medicine approaches for heart conditions.

More Related Videos

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Related Experiment Videos

Last Updated: Dec 30, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Area of Science:

Cardiovascular research
Stem cell biology
Regenerative medicine

Background:

Cardiovascular disease (CVD) remains a leading global cause of mortality.
Human-induced pluripotent stem cells (hiPSCs) technology facilitates the generation of patient-specific cardiomyocytes (CMs).

Discussion:

hiPSC-derived CMs represent a powerful tool for disease modeling and drug screening.
This approach allows for personalized medicine strategies in cardiology.
Investigating individual genetic variations impacting cardiac function.

Key Insights:

Reliable generation of cardiomyocytes from hiPSCs is now feasible.
Patient-specific hiPSC-CMs enable in vitro studies of individual cardiovascular disease mechanisms.
Potential for developing tailored therapeutic interventions for CVD.

Outlook:

Further research into hiPSC-CM differentiation and maturation is crucial.
Clinical applications for hiPSC-based therapies in cardiovascular medicine are anticipated.
Advancing personalized treatment strategies for heart conditions.